Weaver C. Barksdale & Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-31,961
| Closed | -$925K | – | 65 |
|
|
2024
Q3 | $925K | Sell |
31,961
-1,691
| -5% | -$49.3K | 0.83% | 59 |
|
|
2024
Q2 | $942K | Sell |
33,652
-802
| -2% | -$22.1K | 0.89% | 59 |
|
|
2024
Q1 | $955K | Sell |
34,454
-404
| -1% | -$11.2K | 0.88% | 60 |
|
|
2023
Q4 | $1M | Sell |
34,858
-11,897
| -25% | -$360K | 0.98% | 56 |
|
|
2023
Q3 | $1.55M | Buy |
46,755
+2,250
| +5% | +$79.6K | 1.32% | 47 |
|
|
2023
Q2 | $1.63M | Buy |
44,505
+8,968
| +25% | +$349K | 1.61% | 41 |
|
|
2023
Q1 | $1.45M | Sell |
35,537
-1,885
| -5% | -$81.4K | 1.36% | 49 |
|
|
2022
Q4 | $1.92M | Buy |
37,422
+1,050
| +3% | +$50.3K | 1.69% | 31 |
|
|
2022
Q3 | $1.59M | Sell |
36,372
-1,445
| -4% | -$70.2K | 1.6% | 33 |
|
|
2022
Q2 | $1.98M | Buy |
37,817
+382
| +1% | +$19.5K | 1.85% | 12 |
|
|
2022
Q1 | $1.94M | Buy |
37,435
+521
| +1% | +$27K | 1.73% | 26 |
|
|
2021
Q4 | $2.18M | Buy |
+36,914
| New | +$1.83M | 1.98% | 13 |
|
|
2017
Q4 | $1.52M | Sell |
44,134
-186
| -0.4% | -$6.34K | 1.59% | 28 |
|
|
2017
Q3 | $1.5M | Buy |
44,320
+648
| +1% | +$20.8K | 1.67% | 22 |
|
|
2017
Q2 | $1.39M | Hold |
43,672
| – | – | 1.62% | 27 |
|
|
2017
Q1 | $1.42M | Buy |
43,672
+11,159
| +34% | +$352K | 1.67% | 24 |
|
|
2016
Q4 | $1M | Buy |
32,513
+3,171
| +11% | +$96.8K | 1.61% | 14 |
|
|
2016
Q3 | $943K | Buy |
29,342
+2,622
| +10% | +$87.7K | 1.58% | 24 |
|
|
2016
Q2 | $893K | Hold |
26,720
| – | – | 1.55% | 26 |
|
|
2016
Q1 | $751K | Sell |
26,720
-79
| -0.3% | -$2.26K | 0.56% | 75 |
|
|
2015
Q4 | $821K | Hold |
26,799
| – | – | 0.64% | 56 |
|
|
2015
Q3 | $799K | Hold |
26,799
| – | – | 0.64% | 51 |
|
|
2015
Q2 | $853K | Buy |
26,799
+747
| +3% | +$24.3K | 0.63% | 51 |
|
|
2015
Q1 | $860K | Buy |
+26,052
| New | +$828K | 0.65% | 40 |
|
Other funds holding PFE
